Financials Shinva Medical Instrument Co.,Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
22.28 ^CNY	+1.00%		+10.74%	-13.61%

Mar. 28	Shinva Medical Instrument Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Jinan Xinhua Hospital Investment Management Co., Ltd. announced that it expects to receive CNY 140 million in funding from Shinva Medical Instrument Co.,Ltd.	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	5,779	13,087	8,825	12,036	10,398	-	-
Enterprise Value (EV) ¹	5,779	13,087	8,825	12,036	10,398	10,398	10,398
P/E ratio	24.5 x	23.5 x	17.4 x	18 x	12.7 x	10 x	8.97 x
Yield	-	-	-	-	1.21%	1.48%	2.02%
Capitalization / Revenue	-	1.38 x	-	1.2 x	0.95 x	0.83 x	0.78 x
EV / Revenue	-	1.38 x	-	1.2 x	0.95 x	0.83 x	0.78 x
EV / EBITDA	-	13.8 x	-	12.2 x	9.5 x	7.53 x	7.21 x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Price to Book	-	2.66 x	-	1.64 x	1.3 x	1.2 x	1.05 x
Nbr of stocks (in thousands)	406,428	406,428	411,975	466,682	466,682	-	-
Reference price ²	14.22	32.20	21.42	25.79	22.28	22.28	22.28
Announcement Date	4/29/21	4/28/22	3/30/23	3/28/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	9,482	-	10,012	10,946	12,588	13,274
EBITDA ¹	-	949.8	-	989.1	1,095	1,381	1,442
EBIT ¹	-	720.2	-	757	933.5	1,207	1,318
Operating Margin	-	7.6%	-	7.56%	8.53%	9.59%	9.93%
Earnings before Tax (EBT) ¹	-	718	-	738.6	921.5	1,198	1,304
Net income ¹	234.1	556.5	502.6	654	816.8	1,038	1,158
Net margin	-	5.87%	-	6.53%	7.46%	8.25%	8.73%
EPS ²	0.5800	1.370	1.230	1.430	1.750	2.227	2.485
Free Cash Flow	-	-	-	-	-	-	-
FCF margin	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	0.2700	0.3300	0.4500
Announcement Date	4/29/21	4/28/22	3/30/23	3/28/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-
ROE (net income / shareholders' equity)	-	12%	-	9.47%	10.2%	12%	11.8%
ROA (Net income/ Total Assets)	-	4.8%	-	-	5%	5.83%	5.55%
Assets ¹	-	11,584	-	-	16,337	17,802	20,874
Book Value Per Share ²	-	12.10	-	15.70	17.10	18.60	21.20
Cash Flow per Share ²	-	3.450	-	2.210	3.080	3.080	4.240
Capex ¹	-	-	-	533	221	239	235
Capex / Sales	-	-	-	5.33%	2.02%	1.89%	1.77%
Announcement Date	4/29/21	4/28/22	3/30/23	3/28/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.28 CNY

Average target price

31.53 CNY

Spread / Average Target

+41.52%

	1st Jan change	Capi.
SHINVA MEDICAL INSTRUMENT CO.,LTD.	-13.61%	1.43B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B